MedPath

Antenatal Ultrasound Diagnosis of Periventricular Pseudocysts and Postnatal Outcome

Not Applicable
Completed
Conditions
Periventricular Pseudocysts
Interventions
Other: questionnaire
Registration Number
NCT05546801
Lead Sponsor
University Hospital, Bordeaux
Brief Summary

The present study aims to improve the information given to the parents during the screening of periventricular pseudocysts in the Pluridisciplinary Center of Prenatal Diagnosis, with retrospective cases screened during the last 5 years in university hospital of Bordeaux.

Detailed Description

Antenatal ultrasound screening for periventricular pseudocysts is steadily increasing, enabled in part by technological advances in ultrasound equipment.

Most of studies dealing with periventricular pseudocysts and subsequent neurodevelopment are based on neonatal screening, mostly performed in neonatal units.

Current data in the literature on the postnatal outcome of children screened antenatally are scarce; there are only 5 cohort studies with small numbers on the subject.

The present study aims to improve the information given to the parents during the screening of periventricular pseudocysts in the Pluridisciplinary Center of Prenatal Diagnosis, with retrospective cases screened during the last 5 years in university hospital of Bordeaux.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Adult patient diagnosed with a periventricular cyst during a prenatal ultrasound at Bordeaux University Hospital between January 1, 2016 and December 31, 2020.
  • Patient affiliated with or benefiting from a social security plan.
  • Oral informed consent.
Exclusion Criteria
  • Subarachnoid cyst
  • Blake's pouch cyst
  • Choroid plexus cyst
  • Periventricular leukomalacia
  • Poor understanding of French
  • Patient under legal protection.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
questionnairequestionnaireQuestionnaire on postnatal development
Primary Outcome Measures
NameTimeMethod
postnatal child developmentBaseline

composite criterion as follows: Delayed acquisition is defined according to the standards of the Pediatric Society: age of sitting \> 8 months, age of walking \> 18 months, ability or not to associate 3 words at age 3. The use of a medical profession concerns follow-up by a speech therapist, a psychomotrician or a physiotherapist. It is not necessarily a periodic follow-up but a minimum of 2 consultations after the "assessment" consultation.

The scoring defines 2 groups,

* children with 0 points considered with a "normal" post-natal development

* children with 1 point or more considered with a post-natal development disorder.

Secondary Outcome Measures
NameTimeMethod
mother's medical historyBaseline

mother's medical history

medical history of the childBaseline

medical history of the child

Trial Locations

Locations (1)

CHU Bordeaux

🇫🇷

Bordeaux, France

© Copyright 2025. All Rights Reserved by MedPath